ALC
Price
$74.82
Change
+$0.74 (+1.00%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
36.28B
27 days until earnings call
Intraday Buy/Sell Signals
CZMWY
Price
$53.15
Change
+$0.14 (+0.26%)
Updated
Oct 14 closing price
Capitalization
4.67B
56 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ALC vs CZMWY

Header iconALC vs CZMWY Comparison
Open Charts ALC vs CZMWYBanner chart's image
Alcon
Price$74.82
Change+$0.74 (+1.00%)
Volume$600
Capitalization36.28B
Carl Zeiss Meditec AG
Price$53.15
Change+$0.14 (+0.26%)
Volume$1.19K
Capitalization4.67B
ALC vs CZMWY Comparison Chart in %
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALC vs. CZMWY commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Hold and CZMWY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (ALC: $74.08 vs. CZMWY: $53.15)
Brand notoriety: ALC and CZMWY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 141% vs. CZMWY: 28%
Market capitalization -- ALC: $36.28B vs. CZMWY: $4.67B
ALC [@Pharmaceuticals: Other] is valued at $36.28B. CZMWY’s [@Pharmaceuticals: Other] market capitalization is $4.67B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $156.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileCZMWY’s FA Score has 1 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • CZMWY’s FA Score: 1 green, 4 red.
According to our system of comparison, CZMWY is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 5 TA indicator(s) are bullish while CZMWY’s TA Score has 5 bullish TA indicator(s).

  • ALC’s TA Score: 5 bullish, 3 bearish.
  • CZMWY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALC is a better buy in the short-term than CZMWY.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а -1.71% price change this week, while CZMWY (@Pharmaceuticals: Other) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.55%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +15.10%.

Reported Earning Dates

ALC is expected to report earnings on Nov 12, 2025.

CZMWY is expected to report earnings on Dec 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($36.3B) has a higher market cap than CZMWY($4.67B). ALC has higher P/E ratio than CZMWY: ALC (34.30) vs CZMWY (26.79). CZMWY YTD gains are higher at: 12.955 vs. ALC (-12.734). ALC has higher annual earnings (EBITDA): 2.74B vs. CZMWY (226M). ALC has more cash in the bank: 1.41B vs. CZMWY (51.5M). CZMWY has less debt than ALC: CZMWY (147M) vs ALC (5.25B). ALC has higher revenues than CZMWY: ALC (10B) vs CZMWY (2.18B).
ALCCZMWYALC / CZMWY
Capitalization36.3B4.67B777%
EBITDA2.74B226M1,214%
Gain YTD-12.73412.955-98%
P/E Ratio34.3026.79128%
Revenue10B2.18B459%
Total Cash1.41B51.5M2,734%
Total Debt5.25B147M3,572%
FUNDAMENTALS RATINGS
ALC vs CZMWY: Fundamental Ratings
ALC
CZMWY
OUTLOOK RATING
1..100
1414
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
8579
PRICE GROWTH RATING
1..100
8463
P/E GROWTH RATING
1..100
7039
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CZMWY's Valuation (30) in the null industry is somewhat better than the same rating for ALC (70) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew somewhat faster than ALC’s over the last 12 months.

ALC's Profit vs Risk Rating (66) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CZMWY (100) in the null industry. This means that ALC’s stock grew somewhat faster than CZMWY’s over the last 12 months.

CZMWY's SMR Rating (79) in the null industry is in the same range as ALC (85) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.

CZMWY's Price Growth Rating (63) in the null industry is in the same range as ALC (84) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.

CZMWY's P/E Growth Rating (39) in the null industry is in the same range as ALC (70) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCCZMWY
RSI
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDVY37.630.59
+1.59%
First Trust SMID Cp Rising Div Achv ETF
FLEU32.040.18
+0.55%
Franklin FTSE Eurozone ETF
LABU107.36-0.59
-0.55%
Direxion Daily S&P Biotech Bull 3X ETF
FT8.05-0.06
-0.74%
Franklin Universal Trust
ION40.88-0.88
-2.10%
ProShares S&P Global Cor Btty Mtls ETF

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
+2.04%
SYK - ALC
54%
Loosely correlated
+1.39%
A - ALC
54%
Loosely correlated
-0.14%
DHR - ALC
53%
Loosely correlated
+0.49%
TMO - ALC
53%
Loosely correlated
+0.24%
COO - ALC
51%
Loosely correlated
+2.76%
More

CZMWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
+0.26%
SMMNY - CZMWY
44%
Loosely correlated
-1.45%
SONVY - CZMWY
38%
Loosely correlated
-0.46%
SAUHY - CZMWY
37%
Loosely correlated
+0.65%
ALGN - CZMWY
37%
Loosely correlated
+0.19%
ALC - CZMWY
36%
Loosely correlated
+2.04%
More